“Pathological complete response after neoadjuvant cyclin-dependent kinase 4/6 inhibitor and neoadjuvant endocrine therapy in locally advanced hormone receptor-positive breast cancer”, Indian J Case Reports, vol. 10, no. 10, pp. 322–324, Sep. 2024, doi: 10.32677/ijcr.v10i10.4727.